Today: 26 June 2026
Browse Category

Stock Market 28 January 2026

BHP share price hits new high on ASX as gold tops $5,200 and RBA hike bets build

BHP share price hits new high on ASX as gold tops $5,200 and RBA hike bets build

BHP shares closed up 1.8% at A$50.64, reaching a 52-week high as core inflation in Australia jumped past forecasts, fueling bets on an RBA rate hike next week. The S&P/ASX 200 slipped 0.1%, with gains in resource stocks offset by declines elsewhere. The Australian dollar hit a three-year high above 70 U.S. cents. Traders are watching BHP’s interim results and commodity price swings.
28 January 2026
···
Woodside Energy share price jumps after Q4 report, but 2026 output dip keeps traders cautious

Woodside Energy share price jumps after Q4 report, but 2026 output dip keeps traders cautious

Woodside Energy shares rose 2.7% to A$24.98 after its fourth-quarter update, despite forecasting lower 2026 output due to scheduled downtime at Pluto LNG. December-quarter revenue fell to $3.035 billion from $3.484 billion a year earlier. Scarborough project is 94% complete, with first LNG cargo expected in late 2026. Investors await the annual report briefing on Feb. 24.
28 January 2026
···
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 28.01.2026

Bleecker (BLEE.PA) pre-market volume on Euronext jumped to 199 shares, nearly 100 times average, sending the price from €110 to €115. India's Sensex dropped 275 points and the rupee hit a record low as investors awaited the budget. Asian shares mostly fell after the Fed held rates steady; gold surged over 4% to $5,520 an ounce.
28 January 2026
·
Why Gilead stock hit a fresh 52-week high as Medicare targets Biktarvy and earnings loom

Why Gilead stock hit a fresh 52-week high as Medicare targets Biktarvy and earnings loom

Gilead Sciences shares rose 2.3% to $140.97 Tuesday, hitting a 52-week high after Medicare named its HIV drug Biktarvy for price negotiations starting in 2028. Trading volume topped 10.5 million shares. CEO Daniel O’Day sold 115,640 shares last week under a pre-set plan. Gilead will report fourth-quarter and full-year results after markets close on Feb. 10.
28 January 2026
···
HCA stock jumps after earnings and a $10B buyback — what to watch before Wednesday’s open

HCA stock jumps after earnings and a $10B buyback — what to watch before Wednesday’s open

HCA Healthcare shares surged 7.1% to $505.84 after the company raised its 2026 profit outlook and approved a new $10 billion share buyback. Fourth-quarter revenue rose 6.7% to $19.51 billion, with net income at $1.88 billion. Investors remain cautious as ACA exchange subsidies expire, potentially reducing patient volumes. The board also declared a $0.78 quarterly dividend, payable March 31.
28 January 2026
··
Coinbase stock in focus: Cantor’s $277 call clashes with UK ad ban as Fed looms

Coinbase stock in focus: Cantor’s $277 call clashes with UK ad ban as Fed looms

Coinbase shares fell 1.2% to $210.83 in after-hours trading Tuesday, despite Cantor Fitzgerald starting coverage with an Overweight rating and a $277 price target. Britain’s ad regulator banned a Coinbase campaign, saying it downplayed crypto risks; Coinbase disputed the ruling. Bitcoin rose 0.7% to $89,313, while Ether gained 2.6%. Coinbase’s next earnings report is pending.
28 January 2026
··
Rocket Lab stock jumps, but Neutron setback keeps investors on edge ahead of February results

Rocket Lab stock jumps, but Neutron setback keeps investors on edge ahead of February results

Rocket Lab shares rose 8% Tuesday before slipping after hours, following a recent Neutron Stage 1 tank rupture that cast uncertainty on the rocket’s launch timeline. The stock traded near $87, up from $80.48, after rebounding from a 9.5% drop Monday. Investors await the late-February earnings call for updates on the Neutron program. The company also secured an $816 million U.S. defense contract.
28 January 2026
···
Starbucks stock dips as supply-chain snags and CEO jet policy land ahead of earnings

Starbucks stock dips as supply-chain snags and CEO jet policy land ahead of earnings

Starbucks shares fell 0.6% to $95.72 Tuesday ahead of its fiscal first-quarter earnings report set for Wednesday morning. CEO Brian Niccol is under scrutiny as supply-chain issues persist despite new technology and system upgrades. The company also removed the $250,000 cap on Niccol’s personal use of the corporate jet after a security review. Wall Street analysts adjusted price targets as investors focus on sales and margins.
28 January 2026
··
Carvana stock rises after Wells Fargo target hike, but options traders lean defensive

Carvana stock rises after Wells Fargo target hike, but options traders lean defensive

Carvana shares closed up 0.9% at $477.75 after volatile trading Tuesday. Wells Fargo raised its price target to $525, citing strong retail trends but flagged possible weather-related risks. Options trading showed a surge in put buying ahead of the Fed decision and Carvana’s Feb. 18 earnings. Implied volatility remained high, with puts outnumbering calls by nearly two to one.
28 January 2026
·
Constellation Energy stock closes higher as PJM data-center rule overhaul keeps power prices in focus

Constellation Energy stock closes higher as PJM data-center rule overhaul keeps power prices in focus

Constellation Energy closed up 1.2% at $288.76 Tuesday, after trading between $282.50 and $290.40. PJM Interconnection advanced a fast-track plan for data-center hookups and began talks on a government-backed “backstop” auction for new power capacity. Traders are watching natural-gas volatility and PJM/FERC policy moves. Constellation’s next earnings update is expected Feb. 17.
28 January 2026
··
1 … 551 552 553 554 555 … 1,593

Stock Market Today

  • SELLAS Life Sciences Shares Surge Amid Rising Short Interest and Change-Control Filing
    June 26, 2026, 10:49 AM EDT. SELLAS Life Sciences (NASDAQ:SLS) shares rose 6.3% to $11.19, outperforming the biotech sector as short interest reached 63.36 million shares, or 32.65% of float. The company filed a Form 8-K updating severance terms for executives ahead of a key acute myeloid leukemia (AML) trial update. Short sellers increasingly targeted the stock, with 52.68% of off-exchange volume marked short on June 25. SELLAS holds about $107 million in cash plus recent warrant proceeds, valuing cash per share at roughly $0.69. The approaching final analysis of its Phase 3 AML trial, with 78 of 80 required patient deaths reported, underpins investor focus amid high short interest and robust trading volumes.

Latest News

EchoStar (ECHO) reset pulls attention to AT&T cash and SpaceX index moves

EchoStar (ECHO) reset pulls attention to AT&T cash and SpaceX index moves

26 June 2026
EchoStar’s new ECHO ticker plunged 6.5% in its first two sessions as investors weighed the $20.25 billion pending AT&T cash—equal to 71% of EchoStar’s equity value—while the stock rebounded 1.7% Friday; the timing of AT&T deal closing and SpaceX’s Russell index addition now loom large for EchoStar’s price.
Go toTop